BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 32678953)

  • 1. Clinical characteristics, management and outcome of COVID-19-associated immune thrombocytopenia: a French multicentre series.
    Mahévas M; Moulis G; Andres E; Riviere E; Garzaro M; Crickx E; Guillotin V; Malphettes M; Galicier L; Noel N; Darnige L; Terriou L; Guerveno C; Sanchis-Borja M; Moulinet T; Meunier B; Ebbo M; Michel M; Godeau B
    Br J Haematol; 2020 Aug; 190(4):e224-e229. PubMed ID: 32678953
    [No Abstract]   [Full Text] [Related]  

  • 2. Evans syndrome and immune thrombocytopenia in two patients with COVID-19.
    Georgy JT; Jayakaran JAJ; Jacob AS; Gunasekaran K; Korula PJ; Devasia AJ; Iyadurai R
    J Med Virol; 2021 May; 93(5):2642-2644. PubMed ID: 33634495
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune thrombocytopenia following multisystem inflammatory syndrome in children (MIS-C) - a case series.
    Kok EY; Srivaths L; Grimes AB; Vogel TP; Sexson Tejtel SK; Muscal E
    Pediatr Hematol Oncol; 2021 Oct; 38(7):663-668. PubMed ID: 33949910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Thrombocytopenia Secondary to COVID-19 Infection.
    Kupietzky A; Parnasa E; Fischer M; Kuint R; Daana M
    Isr Med Assoc J; 2021 Jun; 23(6):342-343. PubMed ID: 34155845
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune Thrombocytopenic Purpura (ITP) Triggered by COVID-19 Infection and Vaccination.
    David P; Dotan A; Mahroum N; Shoenfeld Y
    Isr Med Assoc J; 2021 Jun; 23(6):378-380. PubMed ID: 34155853
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immune thrombocytopenia preceded by asymptomatic COVID-19 infection].
    Ochiai T; Ando J; Harada S; Hiki M; Ando M; Komatsu N
    Rinsho Ketsueki; 2021; 62(1):58-60. PubMed ID: 33551428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia.
    Crickx E; Moulis G; Ebbo M; Terriou L; Briantais A; Languille L; Limal N; Guillet S; Michel M; Mahevas M; Godeau B
    Br J Haematol; 2021 Dec; 195(5):703-705. PubMed ID: 34467525
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19-associated immune thrombocytopenia.
    Bomhof G; Mutsaers PGNJ; Leebeek FWG; Te Boekhorst PAW; Hofland J; Croles FN; Jansen AJG
    Br J Haematol; 2020 Jul; 190(2):e61-e64. PubMed ID: 32420612
    [No Abstract]   [Full Text] [Related]  

  • 9. Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case.
    Hindilerden F; Yonal-Hindilerden I; Akar E; Kart-Yasar K
    Thromb Res; 2020 Nov; 195():136-138. PubMed ID: 32688098
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe immune thrombocytopenia in a critically ill COVID-19 patient.
    Martincic Z; Skopec B; Rener K; Mavric M; Vovko T; Jereb M; Lukic M
    Int J Infect Dis; 2020 Oct; 99():269-271. PubMed ID: 32771636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does COVID-19 Provide a Clue for Thrombosis in ITP?
    Thachil J
    Semin Thromb Hemost; 2021 Jun; 47(4):463-466. PubMed ID: 33482679
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute immune thrombocytopenia following SARS-CoV-2 vaccination in chronic ITP patients and a healthy individual.
    Ogai A; Yoshida R; Yuasa C; Chin K; Fujimaki K; Nakajima H
    Int J Hematol; 2022 Feb; 115(2):293-295. PubMed ID: 34716890
    [No Abstract]   [Full Text] [Related]  

  • 13. Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection.
    Merli M; Ageno W; Sessa F; Salvini M; Caramazza D; Mora B; Rossi A; Rovelli C; Passamonti F; Grossi P
    Ann Hematol; 2020 Aug; 99(8):1951-1952. PubMed ID: 32529284
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura.
    Chanut M; Jaidi R; Kohn M; Grange T; Brones C; Lombion N; Rousselot P; Longval T
    Platelets; 2022 May; 33(4):652-653. PubMed ID: 35225144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Thrombocytopenia Following the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine.
    Ganzel C; Ben-Chetrit E
    Isr Med Assoc J; 2021 Jun; 23(6):341. PubMed ID: 34155844
    [No Abstract]   [Full Text] [Related]  

  • 16. Incidence, characteristics and clinical profile of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with pre-existing primary immune thrombocytopenia (ITP) in Spain.
    Mingot-Castellano ME; Alcalde-Mellado P; Pascual-Izquierdo C; Perez Rus G; Calo Pérez A; Martinez MP; López-Jaime FJ; Abalo Perez L; Gonzalez-Porras JR; López Fernández F; Caparrós Miranda IS; González-López TJ; Moreno Beltrán ME; Rubio Escuin R; Jimenez Bárcenas R;
    Br J Haematol; 2021 Aug; 194(3):537-541. PubMed ID: 33991422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19-Associated Immune Thrombocytopenia in a Toddler: Authors' Reply.
    Vadakkekara J; Mathew R; Khera S
    Indian J Pediatr; 2022 Sep; 89(9):948. PubMed ID: 35723844
    [No Abstract]   [Full Text] [Related]  

  • 18. De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring.
    Moulis G; Crickx E; Thomas L; Massy N; Mahévas M; Valnet-Rabier MB; Atzenhoffer M; Michel M; Godeau B; Bagheri H; Salvo F;
    Blood; 2022 Apr; 139(16):2561-2565. PubMed ID: 35446373
    [No Abstract]   [Full Text] [Related]  

  • 19. Challenges for management of immune thrombocytopenia during COVID-19 pandemic.
    Sahu KK; Siddiqui AD; Rezaei N; Cerny J
    J Med Virol; 2020 Nov; 92(11):2277-2282. PubMed ID: 32619062
    [No Abstract]   [Full Text] [Related]  

  • 20. Correspondence in reference to the previously published Epub manuscript: immune thrombocytopenic purpura after SARS-CoV-2 vaccine.
    Scanvion Q; Lambert M; Hachulla E; Terriou L
    Br J Haematol; 2021 Sep; 194(6):e93-e95. PubMed ID: 34114220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.